Ennovabio
Shanghai
About Ennovabio
Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $24.0M
- Last round: Series Unknown (Sep 2025)
- Website: ennovabio.com
- Phone: +86 021-50821573
Industries & Categories
Biopharma, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/ennovabio-98812 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.